These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 27267365)

  • 21. Prevalence of pfdhfr and pfdhps mutations in Plasmodium falciparum associated with drug resistance among pregnant women receiving IPTp-SP at Msambweni County Referral Hospital, Kwale County, Kenya.
    Gikunju SW; Agola EL; Ondondo RO; Kinyua J; Kimani F; LaBeaud AD; Malhotra I; King C; Thiong'o K; Mutuku F
    Malar J; 2020 May; 19(1):190. PubMed ID: 32448228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan.
    Al-Saai S; Kheir A; Abdel-Muhsin AM; Al-Ghazali A; Nwakanma D; Swedberg G; Babiker HA
    Infect Genet Evol; 2009 Sep; 9(5):778-83. PubMed ID: 19379843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence of Sulfadoxine-Pyrimethamine Resistance Despite Reduction of Drug Pressure in Malawi.
    Artimovich E; Schneider K; Taylor TE; Kublin JG; Dzinjalamala FK; Escalante AA; Plowe CV; Laufer MK; Takala-Harrison S
    J Infect Dis; 2015 Sep; 212(5):694-701. PubMed ID: 25672905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum isolates obtained from asymptomatic pregnant women in Ogun State, Southwest Nigeria.
    Fagbemi KA; Adebusuyi SA; Nderu D; Adedokun SA; Pallerla SR; Amoo AOJ; Thomas BN; Velavan TP; Ojurongbe O
    Infect Genet Evol; 2020 Nov; 85():104503. PubMed ID: 32805431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique.
    Enosse S; Magnussen P; Abacassamo F; Gómez-Olivé X; Rønn AM; Thompson R; Alifrangis M
    Malar J; 2008 Jul; 7():115. PubMed ID: 18590577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing prevalence of a novel triple-mutant dihydropteroate synthase genotype in Plasmodium falciparum in western Kenya.
    Lucchi NW; Okoth SA; Komino F; Onyona P; Goldman IF; Ljolje D; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3995-4002. PubMed ID: 25896703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High Frequency Mutations in
    Yan H; Feng J; Yin JH; Huang F; Kong XL; Lin KM; Zhang T; Feng XY; Zhou SS; Cao JP; Xia ZG
    Front Cell Infect Microbiol; 2021; 11():673194. PubMed ID: 34568082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine among pregnant women at first antenatal clinic attendance and delivery in the forest-savannah area of Ghana.
    Dosoo DK; Bailey JA; Asante KP; Oppong FB; Niaré K; Opoku-Mensah J; Owusu-Agyei S; Greenwood B; Chandramohan D
    PLoS One; 2022; 17(8):e0271489. PubMed ID: 35939419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Origins and spread of novel genetic variants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates in Indonesia.
    Basuki S; Fitriah ; Risamasu PM; Kasmijati ; Ariami P; Riyanto S; Hidayat A; Susilowati D; Iskandar ; Armika B; Budiono ; Dachlan YP; Kanbara H; Uemura H
    Malar J; 2018 Dec; 17(1):475. PubMed ID: 30558597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya.
    Iriemenam NC; Shah M; Gatei W; van Eijk AM; Ayisi J; Kariuki S; Vanden Eng J; Owino SO; Lal AA; Omosun YO; Otieno K; Desai M; ter Kuile FO; Nahlen B; Moore J; Hamel MJ; Ouma P; Slutsker L; Shi YP
    Malar J; 2012 Jul; 11():134. PubMed ID: 22540158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surveillance of molecular markers for antimalarial resistance in Zambia: Polymorphism of Pfkelch 13, Pfmdr1 and Pfdhfr/Pfdhps genes.
    Sitali L; Mwenda MC; Miller JM; Bridges DJ; Hawela MB; Hamainza B; Mudenda-Chilufya M; Chizema-Kawesha E; Daniels RF; Eisele TP; Nerland AH; Chipeta J; Lindtjorn B
    Acta Trop; 2020 Dec; 212():105704. PubMed ID: 33002448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of Plasmodium falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia.
    Hailemeskel E; Kassa M; Taddesse G; Mohammed H; Woyessa A; Tasew G; Sleshi M; Kebede A; Petros B
    Acta Trop; 2013 Dec; 128(3):636-41. PubMed ID: 24055717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V.
    Oguike MC; Falade CO; Shu E; Enato IG; Watila I; Baba ES; Bruce J; Webster J; Hamade P; Meek S; Chandramohan D; Sutherland CJ; Warhurst D; Roper C
    Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):220-229. PubMed ID: 27821281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine-pyrimethamine in Tanzania.
    Kavishe RA; Kaaya RD; Nag S; Krogsgaard C; Notland JG; Kavishe AA; Ishengoma D; Roper C; Alifrangis M
    Malar J; 2016 Jun; 15():335. PubMed ID: 27339129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular epidemiology of drug-resistant Plasmodium falciparum in Benguela province, Angola.
    Foumane Ngane V; Allico Djaman J; Culeux C; Piette N; Carnevale P; Besnard P; Fortes F; Basco LK; Tahar R
    Malar J; 2015 Mar; 14():113. PubMed ID: 25889865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan.
    Ghanchi NK; Ursing J; Beg MA; Veiga MI; Jafri S; Mårtensson A
    Malar J; 2011 Jan; 10():18. PubMed ID: 21272384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High prevalence of sulfadoxine/pyrimethamine-resistant alleles of Plasmodium falciparum isolates in pregnant women at the time of introduction of intermittent preventive treatment with sulfadoxine/pyrimethamine in Gabon.
    Bouyou-Akotet MK; Mawili-Mboumba DP; Tchantchou Tde D; Kombila M
    J Antimicrob Chemother; 2010 Mar; 65(3):438-41. PubMed ID: 20053688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High prevalence of pfdhfr-pfdhps triple mutations associated with anti-malarial drugs resistance in Plasmodium falciparum isolates seven years after the adoption of sulfadoxine-pyrimethamine in combination with artesunate as first-line treatment in Iran.
    Rouhani M; Zakeri S; Pirahmadi S; Raeisi A; Djadid ND
    Infect Genet Evol; 2015 Apr; 31():183-9. PubMed ID: 25653131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular markers of antifolate resistance in Plasmodium falciparum isolates from Luanda, Angola.
    Gama BE; Pereira-Carvalho GA; Lutucuta Kosi FJ; Almeida de Oliveira NK; Fortes F; Rosenthal PJ; do Rosário VE; Daniel-Ribeiro CT; de Fátima Ferreira-da-Cruz M
    Malar J; 2011 Aug; 10():248. PubMed ID: 21864379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxine-pyrimethamine resistance in a low-transmission area in South America.
    McCollum AM; Mueller K; Villegas L; Udhayakumar V; Escalante AA
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2085-91. PubMed ID: 17283199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.